Reading the gene in the eye: Clinical discrimination and confidence-accuracy calibration in genetic frontotemporal dementia

BackgroundClinical evaluation in frontotemporal dementia (FTD) occurs under diagnostic uncertainty, particularly in stages when symptoms are subtle, heterogeneous, and may resemble primary psychiatric disorders. Less attention has been devoted to clinicians' evaluation of judgment reliability.ObjectiveTo characterize clinicians' decision-making and confidence calibration when evaluating individuals at risk for genetic FTD within the Genetic Frontotemporal Dementia Initiative (GENFI) cohort.MethodsTwo analyses were conducted. First, determinants of diagnostic confidence were examined in asymptomatic participants (N = 837) using univariate analysis and logistic regression including demographic, neuropsychological, and clinical factors. Second, clinicians' ability to predict disease, based on mutation status, was evaluated in a subset of asymptomatic individuals (N = 133) using signal detection theory. Discriminability (d'), response bias (c), and metacognitive performance (meta-d' and M-ratio) were estimated from confidence ratings.ResultsLower diagnostic confidence clustered around boundary neuropsychiatric presentations characterized by subtle symptoms, lower cognitive scores, older age, and features including psychiatric history and current depression or anxiety. Clinicians predicted mutation status above chance level (accuracy ≈ 0.71), with better identification of non-carriers than carriers. Metacognitive modelling revealed imperfect calibration between confidence and accuracy (d' ≈ 1.06; meta-d' ≈ 0.85; M-ratio ≈ 0.80), indicating that confidence carried information about reliability but did not fully reflect available evidence.ConclusionsClinical decision-making in genetic FTD shows moderate accuracy, with lower confidence at the interface between neurodegenerative and psychiatric symptoms. Improving clinical decisions requires not only diagnostic accuracy, but also awareness of when judgments are correct. Biomarkers and structured assessments may help identify cases requiring evaluation.

Authors

Institutions

Publication Details

Journal
Journal of Alzheimer s Disease
Published
2026-11-13
DOI
https://doi.org/10.1177/13872877261502871
Primary Topic
Clinical Reasoning and Diagnostic Skills
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Reading the gene in the eye: Clinical discrimination and confidence-accuracy calibration in genetic frontotemporal dementia

John Cornelis Van Swieten, Sherri Lee Jones, Caroline Graff, Raffaella Migliaccio et al.
1 links
Journal of Alzheimer s Disease
Clinical Reasoning and Diagnostic Skills
article

Reading the gene in the eye: Clinical discrimination and confidence-accuracy calibration in genetic frontotemporal dementia

John Cornelis Van Swieten, Sherri Lee Jones, Caroline Graff, Raffaella Migliaccio, Maria Carmela Tartaglia, Tobias Christoph Langheinrich, Eino Solje, James Benedict Rowe, Alexander Gerhard, Matthis Synofzik, Johannes Levin, Johanna Krüger, Alexandre de Mendonça, Alexandre Morin, Eve Ferry‐Bolder, Isabelle Le Ber, Giancarlo Logroscino, Péter Körtvelyessy, Ignacio Illán‐Gala, Harro Seelaar, Jonathan D. Rohrer, Željko Uzelac, Phoebe H. Foster, Rose Bruffaerts, Arabella Bouzigues, Isabel J. Santana, Lize Corrine Jiskoot, Lucy Louise Russell, Markus Otto, Rik R. Vandenberghe, Maxime Bertoux, Elizabeth C. Finger, Kristy K. L. Coleman, Daniela Galimberti, Thibaud Lebouvier, Mario Masellis, Robert Jr Laforce, Rhian S. Convery, Giuseppe Di Fede, Jasmine Carlier, Barbara Borroni, Fermín Moreno, Simon Ducharme, M. Schroeter, Benedetta Nacmias, Alexander Thompson, Sophie Farley, Eva Cullen, Raquel Sanchez‐Valle
article en

Abstract

BackgroundClinical evaluation in frontotemporal dementia (FTD) occurs under diagnostic uncertainty, particularly in stages when symptoms are subtle, heterogeneous, and may resemble primary psychiatric disorders. Less attention has been devoted to clinicians' evaluation of judgment reliability.ObjectiveTo characterize clinicians' decision-making and confidence calibration when evaluating individuals at risk for genetic FTD within the Genetic Frontotemporal Dementia Initiative (GENFI) cohort.MethodsTwo analyses were conducted. First, determinants of diagnostic confidence were examined in asymptomatic participants (N = 837) using univariate analysis and logistic regression including demographic, neuropsychological, and clinical factors. Second, clinicians' ability to predict disease, based on mutation status, was evaluated in a subset of asymptomatic individuals (N = 133) using signal detection theory. Discriminability (d'), response bias (c), and metacognitive performance (meta-d' and M-ratio) were estimated from confidence ratings.ResultsLower diagnostic confidence clustered around boundary neuropsychiatric presentations characterized by subtle symptoms, lower cognitive scores, older age, and features including psychiatric history and current depression or anxiety. Clinicians predicted mutation status above chance level (accuracy ≈ 0.71), with better identification of non-carriers than carriers. Metacognitive modelling revealed imperfect calibration between confidence and accuracy (d' ≈ 1.06; meta-d' ≈ 0.85; M-ratio ≈ 0.80), indicating that confidence carried information about reliability but did not fully reflect available evidence.ConclusionsClinical decision-making in genetic FTD shows moderate accuracy, with lower confidence at the interface between neurodegenerative and psychiatric symptoms. Improving clinical decisions requires not only diagnostic accuracy, but also awareness of when judgments are correct. Biomarkers and structured assessments may help identify cases requiring evaluation.

Journal of Alzheimer s Disease
Western University (CA), Montreal Neurological Institute and Hospital (CA), Centre National de la Recherche Scientifique (FR), Sunnybrook Health Science Centre (CA), Karolinska University Hospital (SE), University of Lisbon (PT), University of Antwerp (BE), Inserm (FR), University of Eastern Finland (FI), University of Toronto (CA), University of Milan (IT), Universität Ulm (DE), Université de Lille (FR), University of Cambridge (GB), Oulu University Hospital (FI), Universitair Ziekenhuis Leuven (BE), Instituto de Salud Carlos III (ES), German Center for Neurodegenerative Diseases (DE), McGill University Health Centre (CA), Hospital de Sant Pau (ES), Erasmus MC (NL), Hospitais da Universidade de Coimbra (PT), Cambridge University Hospitals NHS Foundation Trust (GB), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Karolinska Institutet (SE), University of Manchester (GB), Centre Hospitalier Universitaire de Lille (FR), Sorbonne Université (FR), University of Oxford (GB), Institut des Sciences Moléculaires (FR), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), Kuopio University Hospital (FI), Centre hospitalier universitaire de Québec (CA), Assistance Publique – Hôpitaux de Paris (FR), Biogipuzkoa Health Research Institute (ES), Antwerp University Hospital (BE), Salford Royal Hospital (GB), Munich Cluster for Systems Neurology (DE), Centro San Giovanni di Dio Fatebenefratelli (IT), Don Carlo Gnocchi Foundation (IT), Pitié-Salpêtrière Hospital (FR), Centre Hospitalier du Rouvray (FR), Max Planck Institute for Human Cognitive and Brain Sciences (DE), Donostiako Unibertsitate Ospitalea (ES), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Hertie Institute for Clinical Brain Research (DE), Centre Hospitalier de l’Université de Montréal (CA), Institut du Cerveau (FR), Centre Hospitalier Universitaire de Rouen (FR), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Fondazione IRCCS Istituto Neurologico Carlo Besta (IT), Université Laval (CA), Institut de Recerca Sant Pau (ES), Lille Neurosciences & Cognition (FR), Sunnybrook Research Institute (CA), Centro de Neurociências e Biologia Celular (PT), Northern Care Alliance NHS Foundation Trust (GB), UCL Queen Square Institute of Neurology (GB), University of Florence (IT), University College London (GB), Imperial College London (GB), McGill University (CA), University of Bari Aldo Moro (IT), University of Duisburg-Essen (DE), Université de Rouen Normandie (FR), Université Savoie Mont Blanc (FR), Université de Montréal (CA), Universitat de Barcelona (ES), University of Coimbra (PT), Charité - Universitätsmedizin Berlin (DE), University of Brescia (IT), University of Tübingen (DE), Ludwig-Maximilians-Universität München (DE), Hasselt University (BE), Leipzig University (DE), University of Oulu (FI), KU Leuven (BE)
Good health and well-being
Clinical Reasoning and Diagnostic Skills
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon